HeartSciences amends bylaws to add jury waiver, 3% derivative threshold

HeartSciences Inc.

Adds jury trial waiver for 'internal entity claims' under Texas Business Organizations Code.
Requires 3% ownership threshold for shareholders to initiate derivative proceedings.
Technical revisions to clarify exclusive forum provision.
Amendments effective June 27, 2025, filed as Exhibit 3.1.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.